Innovative GFAP blood biomarker test expands Labcorp's (LH) portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April ...
Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...
Technicians at Quest Diagnostics and Labcorp have been refusing to draw blood from people who might have monkeypox, CNN reported Aug. 4. The two lab companies aren’t disputing the claim, but it’s ...
BURLINGTON, N.C., April 15, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the availability of the nation's first test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback